Fresenius Kabi, a part of Fresenius, and a leading provider of essential medicines and medical technologies, announced today that the Centers for Medicare & Medicaid Services has issued ...

Fresenius Kabi has entered a global licensing agreement for the commercialisation of Polpharma Biologics’s vedolizumab biosimilar candidate PB016, except in the Middle East and North Africa. An ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, today ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Romidepsin for Injection, the newest addition to the company’s broad portfolio of ...

The Frankfurt-based parent of hospital drugs firm Kabi raised the unit’s 2023 forecast and operating margin projection as it laid out a road to growth paved by biosimilars, generics and plasma.

Add Yahoo as a preferred source to see more of our stories on Google. Fresenius Kabi recalled some of its large volume infusion pumps over a software problem that can lead to delays or interruptions ...

The drug producer Fresenius Kabi is taking its first steps under a new strategy to bolster its intravenous drug offerings, starting with a $240 million acquisition of the smart infusion pump maker ...

In hospital settings, powerful anesthetics are often reserved for the most critical procedures, and it's important that they work exactly as intended. But Fresenius Kabi slipped on a major banana peel ...

Fresenius Kabi is offering Sincalide for injection, an authorized generic for Bracco Diagnostics’ Kinevac (Sincalide for injection). The new product broadens Fresenius Kabi’s radiology portfolio and ...

FDA has upgraded Fresenius Kabi’s voluntary recall of certain Ivenix Large Volume Pump (LVP) primary administration sets to Class I after the company identified a manufacturing defect that could cause ...

Fresenius Kabi is welcoming a new executive. Arunesh Verma has joined the company as president of Fresenius Kabi USA and a member of the company’s global executive leadership team, reporting to ...

Fresenius Kabi, a provider of infusion therapy and clinical nutrition is to acquire Fenwal, a specialist in separation technologies for blood and cell collection and therapy. Fenwal is owned by TPG ...